Journal profile
Pharmaceutical and Biomedical Research
ISSN 2423-4494 · Mazandaran University of Medical Sciences · Iran, Islamic Republic of
Pharmaceutical and Biomedical Research: diamond open access (no APC); no APC; review about 10 weeks (community reports); 26 articles in 2025.
Scope
Aims, scope and focus
Pharmaceutical and Biomedical Research is published by Mazandaran University of Medical Sciences. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, COVID-19 Clinical Research Studies and Advanced Drug Delivery Systems, together about 29.4% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Pharmaceutical and Biomedical Research (PBR) is a quarterly international peer-reviewed multi-disciplinary pharmaceutical to communicate scientific information in the international pharmaceutical forum. PBR is an internationally oriented journal and actively encourages submissions from researchers across diverse geographic regions. The journal aims to promote global scientific exchange and interdisciplinary collaboration in pharmaceutical and biomedical sciences. The journal welcomes submitted manuscripts in the broad fields of pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical pharmacy, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics, and pharmacology. As an international journal, PBR considers definitive studies from basic research to clinical investigations, such as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community. View: 17790 Time(s) | Print: 1332 Time(s) | Email: 0 Time(s) | 0 Comment(s)
From the journal's Aims & Scope
Editor-in-chief Mohammad Ali EbrahimzadehPublisher website
Editorial board by country: 2 in mainland China (about 9%); most named Iran 8, Pakistan 3, Mainland China 2, India 2, Malaysia 2 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences15%
- COVID-19 Clinical Research StudiesMedicine7.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.4%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics4.2%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 19OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 0.78OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 351 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 14 | 14 | 134 |
| 2025 | 26 | 26 | 256 |
| 2024 | 33 | 33 | 228 |
| 2023 | 33 | 33 | 271 |
| 2022 | 43 | 43 | 219 |
| 2021 | 45 | 45 | 191 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mazandaran University of Medical Sciences
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2423-4494
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Pharmaceutical and Biomedical Research
How long does peer review take at Pharmaceutical and Biomedical Research?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pharmaceutical and Biomedical Research based?
Of the 23 board members whose country the journal's board page names, 2 (about 9%) are in mainland China; the countries named most often are Iran (8), Pakistan (3) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmaceutical and Biomedical Research?
According to LetPub and DOAJ records, Pharmaceutical and Biomedical Research is indexed in DOAJ.
Is Pharmaceutical and Biomedical Research open access, and what is the APC?
Pharmaceutical and Biomedical Research is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .